Aesthetic supplier Healthxchange Pharmacy is now the exclusive UK distributor for aftercare treatments Thoclor GF1 and GF2, manufactured by biotechnology company Thoclor laboratories.
Thorclor explains that the GF1 is an in-clinic aftercare treatment designed to support the skin’s healing process, prevent infection, control inflammation, reduce the risk of scarring and shorten recovery time.
The company states that it can be used for treatments that compromise the outermost layer of the skin, including microneedling, dermaplaning, peels, fillers, laser, waxing and permanent makeup.
The Thoclor GF2 Skin Rejuvenation is an additional treatment that patients can take home and add to their skincare routine. It is specifically designed to combat inflammaging.
Dr John Curran, chairman of Healthxchange Group, commented, “Most cosmetic medical procedures carry a risk of infection and often prolonged inflammation. Thoclor, a novel hypochlorus acid-based system, has the dual quality of effectively eradicating pathogens on the skin, protecting against post-procedure infection and has powerful anti-inflammatory effects; quickly reducing redness.”